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A B S T R A C T
The maintenance of genomic stability is essential for cellular viability and the prevention of diseases such as
cancer. Human single-stranded DNA-binding protein 1 (hSSB1) is a protein with roles in the stabilisation and
restart of stalled DNA replication forks, as well as in the repair of oxidative DNA lesions and double-strand DNA
breaks. In the latter process, phosphorylation of threonine 117 by the ATM kinase is required for hSSB1 stability
and eﬃcient DNA repair. The regulation of hSSB1 in other DNA repair pathways has however remained unclear.
Here we report that hSSB1 is also directly phosphorylated by DNA-PK at serine residue 134. While this
modiﬁcation is largely suppressed in undamaged cells by PPP-family protein phosphatases, S134 phosphoryla-
tion is enhanced following the disruption of replication forks and promotes cellular survival. Together, these
data thereby represent a novel mechanism for hSSB1 regulation following the inhibition of replication.
1. Introduction
DNA replication constitutes one of the most important processes
within the cell and allows for the accurate duplication of genomic
information prior to cell division. While this process occurs rapidly in
unperturbed cells, numerous endogenous and exogenous sources may
either slow or stall replication fork progression [1]. Such disruption
results in the exposure of single-stranded DNA (ssDNA) that must be
stabilised to prevent replication fork collapse and double-stranded DNA
break formation [2]. This process includes the nucleation of replication
protein A (RPA) onto exposed ssDNA, as well as the subsequent
accumulation and activation of the ataxia telangiectasia and Rad3-
related (ATR) kinase [3]. ATR may then phosphorylate Chk1 to
promote cell cycle checkpoint activation [4], as well as other proteins
involved in restarting replication [5]. In addition to ATR, numerous
additional regulatory enzymes are also activated by replication stress,
including the related PI3K-like kinases, ataxia telangiectasia mutated
(ATM) and DNA-dependent protein kinase (DNA-PK) [6–8]. Activation
of these enzymes results in the coordinated regulation of numerous
DNA repair proteins and is exempliﬁed by the ATM, ATR and DNA-PK-
mediated phosphorylation of the RPA 32 kDa subunit (RPA32) [8–10].
Recently our group and others provided evidence that the restart of
stalled replication forks is promoted by human single-stranded DNA-
binding protein 1 (hSSB1; also known as Nucleic Acid Binding Protein 2
NABP2) [11,12], a ssDNA-binding protein that also functions in the
repair of double-stranded DNA breaks [13] and oxidative nucleotide
lesions [14]. Following the disruption of replication, hSSB1 was found
to localise with stalled replication forks where it promotes recruitment
and subsequent activation of the ATR kinase. The importance of hSSB1
in these processes is highlighted by the ineﬃciency of hSSB1-depleted
cells to activate checkpoint signalling following replication stress, as
well as their inability to restart stalled replication forks. These
deﬁciencies are manifested by hypersensitivity to multiple replication
inhibitors [11].
Previous studies have indicated that hSSB1 may be phosphorylated
at threonine residue 117 (T117) [13] and acetylated at lysine residue
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94 (K94) [15], both of which promote hSSB1 function in response to
ionising radiation exposure. Mass spectrometry screens of proteins
immunoprecipitated with phosphorylation and acetylation motif spe-
ciﬁc antibodies have also identiﬁed numerous other potentially mod-
iﬁed hSSB1 residues, although these remain to be validated and have
not been associated with any particular stress or cellular function [16].
Nevertheless, these ﬁndings support that hSSB1 may be highly regu-
lated in cells through post-translational modiﬁcations.
In this study we describe the novel phosphorylation of hSSB1
residue S134 by the central DNA repair kinase DNA-PK and suggest
that this modiﬁcation is important for hSSB1 function following
replication fork inhibition.
2. Materials and methods
2.1. Plasmids and site-directed mutagenesis
The 3x FLAG hSSB1 mammalian expression vector (3DDK-AN-
pCMV6) has been described previously [14], as has the pET28A hexa-
His-hSSB1 E. coli expression construct [13]. Site directed mutagenesis
was used to prepare S134A and siRNA resistant hSSB1 as previously
described [17] using the following primer sets: S134A (F) 5′- GCAAC-
CCTTCAGCTGCCCAGCCTACCAC-3′, (R) 5′-GTGGTAGGCTGGGCAGCT-
GAAGGGTTGC-3′; S134E (F) 5′-CAGCAACCCTTCAGCTGAGCAGCCTA-
CCACTGGAC-3′, (R) 5′-GTCCAGTGGTAGGCTGCTCAGCTGAAGGGTT-
GCTG-3′; siRNA resistance (F) 5′-CAGGCCCGCCTGGCCCTTCTTCCAA-
TCCCGTTAGTAACGGCAAAGAAAC-3′, (R) 5′-GTTTCTTTGCCGTTACT-
AACGGGATTGGAAGAAGGGCCAGGCGGGCCTG-3′.
2.2. Cell culture and treatments
HeLa and HEK293T cell cultures were maintained in Roswell Park
Memorial Institute medium (RPMI, Sigma-Aldrich) supplemented with
10% foetal bovine serum (Sigma-Aldrich) and cultured in a humidiﬁed
incubator with 5% CO2 at 37 °C. Stealth siRNA of the following
sequence 5′-GCCCUUCCAGCAACCCUGUUAGUAA-3′ was used to de-
plete hSSB1 from cells. Silencer Select siRNA (Life Technologies) of
sequence 5′- CAAGCGACUUUAUAGCCUUTT-3′ was used to depleted
DNA-PKcs. Stealth siRNA negative control med GC, or Silencer Select
negative control no.1, were used as negative control siRNAs where
appropriate. Stealth siRNA was used at a concentration of 50 nM, and
Silence Select siRNA at 10 nM. Mammalian expression vectors were
transfected using Lipofectamine 2000 (Life Technologies) or FuGENE
HD (Promega) and siRNA were transfected using Lipofectamine
RNAiMax (Life Technologies). Hydroxyurea, aphidicolin, thymidine
and camptothecin were purchased from Sigma-Aldrich. KU-60019,
VE-821 and NU7441, inhibitors of ATM, ATR and DNA-PK, respec-
tively, were purchased from Selleck Chemicals. KU-60019 and NU7441
were used at a ﬁnal concentration of 5 μM and VE-821 at 10 μM.
Okadaic acid and calyculin A were purchased from Cell Signaling
Technology. Okadaic acid was added to cells at concentrations of 25 nM
or 1 μM. Calyculin A was added to cells at a ﬁnal concentration of
50 nM. Double-strand DNA breaks were induced in cells by exposure to
6 Gy ionising radiation using a Gammacell 40 Exactor caesium-source
irradiator.
2.3. Clonogenic survival assays
Clonogenic survival assays were performed as described previously
[14]. Brieﬂy, HeLa cells were depleted of hSSB1 by transfection with
siRNA twice, separated by a 24 h interval, prior to transient expression
of siRNA-resistant WT, S134A or S134E 3x FLAG hSSB1 24 h later. Cells
were then seeded into wells of a 6-well plate (each dose in triplicate) at
a density of 400 cells per well. 24 h subsequent to over-expression, cells
were treated with 3 mM hydroxyurea or 6 μg μl−1 aphidicolin (B) for 4,
8, 12, 16 or 20 h, or left untreated, prior to washing 2x with PBS and
exchanging with fresh media. Alternatively, cells were treated with
increasing concentrations of camptothecin (50, 100, 150 or 200 nM) for
1 h prior to media exchange, or with increasing doses of ionising
radiation (1, 2, 4 or 6 Gy). Cells were grown for 10 days post-treatment
prior to staining of colonies with methylene blue. Colonies were
manually counted and normalised to untreated cells. Each assay was
performed four times and results presented as the mean ± 1 standard
deviation (SD). Unpaired, two-tailed t tests were performed using the
Holm–Sidak method to assess statistical signiﬁcance between individual
data sets at each dose using GraphPad Prism version 6 software.
p < 0.05 was considered statistically signiﬁcant.
2.4. Cell lysis, immunoblotting and antibodies
Whole cell lysates were prepared by lysis in
Radioimmunoprecipitation buﬀer (RIPA buﬀer; 50 mM Tris pH 8.0,
150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X100)
supplemented with 1x phosphatase inhibitor cocktail (Cell Signaling
Technology) and 1x protease inhibitor cocktail (cOmplete, EDTA free;
Roche), followed by sonication (Vibra-Cell, 3 mm probe; Sonics and
Materials), with 3x 3 s bursts (10% output). 15-20 μg of whole cell
lysate was typically separated by electrophoresis on a 4–12% Bis-Tris
Plus Bolt precast gel (Life Technologies) and transferred to nitrocellu-
lose.
Commercial antibodies against the following targets were pur-
chased from Cell Signaling: p-S345 Chk1 (1:500, clone 133D3, cat #
2348), Chk1 (1:500, clone 2G1D5, cat # 2360), p-T68 Chk2 (1:500,
clone C13C1, cat # 2197), Chk2 (1:500, clone 1C12, cat # 3440), DNA-
PKcs (1:500, clone 3H6, cat # 12311), p-S1981 ATM (1:500, clone
D6H9, cat # 5883), ATM (1:500; clone D2E2, cat # 2873), ATR (1:500,
clone E1S3S, cat # 13934) and RPA32 (1:1000, clone 4E4, cat # 2208).
The antibodies against p-S33 RPA32 (1:1000, cat # A300-46A) and p-
S4/S8 RPA32 (1:2000, cat # A300-245A) were purchased from Bethyl,
the FLAG antibody (1:2000; clone M2, cat # F1804) from Sigma-
Aldrich, the p-S1989 ATR antibody (1:500; cat # GTX128145) from
GeneTex and the Actin antibody (1:10,000 clone C4, cat # 612656)
from BD Biosciences. The hSSB1 antibody was aﬃnity puriﬁed from
previously described sheep anti-serum [13] using recombinant WT
hexa-His-hSSB1 bound to cyanogen-bromide activated sepharose beads
(Sigma-Aldrich) as per the manufacturer's instructions.
To detect pS134 hSSB1, a polyclonal antibody was raised against the
hSSB1 peptide PSA{pS}QPTTGPKC (GenScript). To prevent non-speci-
ﬁc binding of the antibody to non-phosphorylated hSSB1, a 200x molar
excess of a control peptide (PSAQPTTGPKC) was included in all
antibody working-solutions. A 200x molar excess of phosphorylated
peptide was used to block the antibody from binding pS134 hSSB1 in
Fig. 3B. For validation of the antibody, whole cell lysates were
dephosphorylated by addition of 200 Units of lambda (λ) phosphatase
(New England Biolabs) and incubation at 30 °C for 45 min.
Primary antibodies were detected using IRDye 680RD or 800CW-
conjugated donkey anti-mouse, rabbit, goat or rat ﬂuorescent secondary
antibodies (Li-Cor) and visualised using the Odyssey Imaging system
(Li-Cor). When necessary, immunoblots were quantiﬁed using ImageJ
software. Phosphorylation of hSSB1 S134 was expressed relative to
total immunoprecipitated endogenous hSSB1, or to total 3x FLAG
hSSB1, as appropriate. RPA32 phosphorylation was calculated as the
relative ratio of the 34–32 kDa RPA32 bands.
2.5. Immunoprecipitation
Cells were lysed by sonication in immunoprecipitation buﬀer
(20 mM HEPES pH 7.5, 150 mM KCl, 5% glycerol, 10 mM MgCl2,
0.5% Triton X-100) supplemented with 1x phosphatase inhibitor cock-
tail, 1x protease inhibitor cocktail and Benzonase (1:1000, Sigma-
Aldrich). For immunoprecipitation of hSSB1, protein G magnetic
dynabeads (Life Technologies) were prepared by incubation with the
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hSSB1 antibody or with an isotype control IgG (Sigma). Alternatively,
for the precipitation of FLAG-tagged proteins, magnetic anti-FLAG M2
beads (Sigma-Aldrich) were resuspended and prepared by washing in
immunoprecipitation buﬀer. In either instance, whole cell lysates were
incubated with antibody-bound beads for 2 h at 4 °C, beads washed 5x
with immunoprecipitation buﬀer and proteins eluted by heating to
80 °C for 5 min in 3x SDS loading dye. Eluted proteins were separated
by electrophoresis and either immunoblotted or stained with colloidal
Coomassie blue.
2.6. Mass spectrometry
Gel bands were excised and cut into 1 mm cubes. These were then
subjected to in-gel digestion using a ProGest Investigator in-gel diges-
tion robot (Digilab) using standard protocols [18]. Brieﬂy, the gel cubes
were destined by washing with acetonitrile and subjected to reduction
and alkylation before digestion with trypsin at 37 °C. The peptides were
extracted with 5% formic acid and concentrated to a volume of 20 μL,
using a SpeedVac (ThermoSavant). Peptides were then separated on an
Acclaim PepMap 100 C18 trap and an Acclaim PepMap RSLC C18
column (ThermoFisher Scientiﬁc), using a nanoLC Ultra 2D plus
loading pump and nanoLC as-2 autosampler (Eksigent). A quarter
(5 μL) of the sample was loaded. Peptides were eluted with a gradient
of increasing acetonitrile, containing 0.1% formic acid (5–40% acet-
onitrile in 5 min, 40–95% in a further 1 min, followed by 95%
acetonitrile to clean the column, before re-equilibration to 5% acetoni-
trile). The eluate was sprayed into a TripleTOF 5600 electrospray
tandem mass spectrometer (ABSciex) and analysed in Information
Dependent Acquisition (IDA) mode, performing 250 msec of MS
followed by 150 msec MSMS analyses on the 15 most intense peaks
seen by MS. The MS/MS data ﬁle generated was analysed using the
Mascot algorithm (Matrix Science) against the NCBI non-redundant (nr)
database July 2014 with no species restriction, trypsin as the cleavage
enzyme, carbamidomethyl as a ﬁxed modiﬁcation of cysteines and
methionine oxidation, deamidation of glutamines and asparagines and
phosphorylation of serine, threonine and tyrosine as a variable mod-
iﬁcations.
The raw mass spectrometry data and Mascot search ﬁles have been
deposited to the ProteomeXchange Consortium via the PRIDE partner
repository [19] with the dataset identiﬁer PXD003964.
2.7. Protein puriﬁcation
SHuﬄe® T7 Competent E. coli were transformed with plasmids
encoding WT, S134A or S134E hexa-His-hSSB1. Proteins were prepared
as previously described [14]. Concentrations of fully reduced mono-
meric hSSB1 were estimated on SDS-PAGE gels.
2.8. DNA-PK kinase assay
10 U of puriﬁed DNA-PK (Promega) was incubated with 500 ng of
recombinant hSSB1 in 50 μL of kinase buﬀer (20 mM HEPES, 50 mM
NaCl, 10 mM MgCl2, 10 mM MnCl, 1 mM DTT) containing 100 μM ATP
and 10 μg mL−1 sonicated salmon sperm DNA (Invitrogen). Reactions
were incubated for 30 minutes at 30 °C and then stopped by addition of
3x SDS loading dye containing 20% β-mercaptoethanol and heating to
80 °C for 5 min. Samples were electrophoresed in duplicate and either
stained with colloidal coomasie brilliant blue or immunoblotted.
2.9. One dimensional nuclear magnetic resonance spectroscopy (1D-NMR)
WT, S134A or S134E hexa-His hSSB1 (∼ 100-200 μM) was resus-
pended in NMR buﬀer (20 mM Tris pH 6.9, 100 mM NaCl, 1 mM EDTA,
1 mM TCEP) with 10% 2H2O and analysed at 298 K on a Bruker
600 Mhz spectrometer (Bruker Avance III; Bruker) equipped with a
5 mm TCI cryoprobe. Proton chemical shifts are references to 4,4-
dimethyl-4-silapentanesulfonic acid (DSS) at 0 ppm. Data were pro-
cessed using Topspin software (Bruker).
2.10. Synthetic DNA substrates
Biotin-labelled oligonucleotides were purchased from Integrated
DNA Technologies (IDT). The ssDNA and fork junction substrates have
been described previously [20]. Substrates were annealed and puriﬁed
as previously described [21]. Brieﬂy, individual oligonucleotides were
ﬁrstly isolated on 12% polyacrylamide, 8 M urea gels and eluted by
overnight passive diﬀusion in TE buﬀer. Equimolar quantities of
oligonucleotides were then mixed in hybridisation buﬀer (50 mM Tris
pH 7.5, 100 mM NaCl, 10 mM MgCl2), heated at 99 °C for 10 min and
slowly cooled to room temperature. Annealed structures were puriﬁed
on 10% polyacrylamide gels, electro-eluted and concentrated using
EMD Millipore Amicon Ultra-4 centrifugal ﬁlter units with a 3 kDa cut-
oﬀ. Substrate concentrations were determined from absorbance at
260 nm. Here, the oligonucleotide molar extinction coeﬃcients were
calculated by a nearest neighbour approach, taking into account the
hypochromicity of dsDNA.
2.11. BioLayer interferometry (BLI)
DNA-binding studies with WT and S134E recombinant hSSB1 were
performed using a set of seven protein concentrations (6, 4, 2, 1, 0.5,
0.25 and 0.125 μM). Proteins were bound to immobilised 5′-biotiny-
lated DNA constructs (ssDNA and fork-DNA) in triplicate, using the
BLItz system (ForteBio). Streptavidin biosensors (ForteBio) were equili-
brated in DNA buﬀer (10 mM Tris-HCl, 1 mM EDTA, pH 8) prior to use.
For each individual binding curve, an initial 20 s baseline was
performed followed by loading of the biotinylated DNA construct until
saturation (120 s). Two further baselines (20 s each) were carried out to
transition from the DNA buﬀer to protein buﬀer (10 mM phosphate,
50 mM NaCl, 3 mM TCEP, pH 7.5). Both WT and S143E hSSB1 were
allowed 120 s for association, followed by a 20 s dissociation step. The
interaction response level for each binding was calculated by the
diﬀerence between the maximum and minimum BLI values for each
binding curve. These values were plotted against the corresponding
protein concentration and ﬁtted to a steady-state binding model using
the hill equation (n= 1).
3. Results
3.1. Mass spectrometric detection of phosphorylated hSSB1
To further understand the post-translational regulation of hSSB1, 3x
FLAG hSSB1 was immunoprecipitated from HEK293T cells treated with
or without 3 mM hydroxyurea (HU) for 4 h and separated by SDS-PAGE
(Fig. 1A). Bands corresponding to 3x FLAG hSSB1 of ∼ 30 and 35 kDa
were then excised from the gel and subjected to in-gel trypsin digestion.
The resulting peptides were distinguished by qualitative electrospray
ionisation tandem mass spectrometry (ESI-MS/MS) and results analysed
using the Mascot algorithm against the NCBI database. N- and C-
terminal hSSB1 peptides were identiﬁed for the ∼ 30 and 35 kDa
bands, suggesting that both species represent full-length hSSB1 (Fig.
S1A). Potentially phosphorylated serine and threonine residues were
identiﬁed from both bands analysed for each sample (Figs. 1B and S1B).
This included detection of a phosphorylated peptide corresponding to
residues 124–178. Whilst the MS/MS fragmentation of this peptide was
not conclusive enough to conﬁdently determine the site of phosphor-
ylation (Fig. S1C and S1D), we noted that S134 is a component of an SQ
motif. SQ and TQ motifs are often present in DNA repair proteins where
they may be substrates of the DNA repair P13K-like kinases, ATM, ATR
and DNA-PK. Indeed, phosphorylation of hSSB1 T117, a TQ motif, has
previously been described [13]. We therefore reasoned that S134
phosphorylation might also regulate hSSB1 during DNA repair.
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3.2. Cells expressing S134A hSSB1 are more sensitive to replication fork
disruption and double-strand DNA break formation
To determine whether S134 phosphorylation may be important for
the function of hSSB1, clonogenic assays were performed using cells
depleted of endogenous hSSB1 and transiently expressing siRNA-
resistant WT or phospho-mutant S134A 3x FLAG hSSB1 (Fig. 2A).
Initially, cells were incubated with 3 mM hydroxyurea for 4, 8, 12, 16
or 20 h. Consistent with our previously published data [11], hSSB1-
depleted cells were hypersensitive to hydroxyurea treatment, which
could be rescued by re-introduction of exogenous WT hSSB1. Over
expression of S134A hSSB1 was however unable to rescue the sensitiv-
ity associated with hSSB1 depletion (Fig. 2B). HU suppresses new DNA
replication through the inhibition of ribonucleotide reductase and the
disruption of dNTP synthesis within the cell [22]. To conﬁrm that our
ﬁndings were due to fork disruption and not indirect eﬀects of HU
treatment, cells were also treated with 6 μg μL−1 of the DNA poly-
merase α inhibitor aphidicolin (Aph) for the same time periods.
Similarly to HU treatment, hSSB1-depleted cells were hypersensitive
to treatment with Aph, which could be rescued by re-introduction of
WT, although not of S134A, siRNA-resistant 3x FLAG hSSB1 (Fig. 2C).
In addition to the cellular response to replication fork stalling,
hSSB1 has also been implicated in the repair of collapsed replication
forks [11], as well as in the repair of double-strand DNA breaks
throughout the cell cycle [13]. To evaluate whether hSSB1 S134
phosphorylation may also promote cellular survival in response to
these damage events, cells were also treated with increasing doses of
the topoisomerase I inhibitor, camptothecin (Fig. 2D; to cause replica-
tion-associated double-strand DNA-breaks), or exposed to increasing
doses of ionising radiation (Fig. 2E; to induce double-strand DNA-
breaks non-speciﬁcally). As expected, hypersensitivity to either stress
was observed in those cells depleted of hSSB1, which could be rescued
by transient expression of siRNA-resistant WT 3x FLAG hSSB1. Cells
expressing siRNA-resistant S134A 3x FLAG hSSB1 were however
similarly sensitive to those depleted of hSSB1. These data thereby
suggest that as well as in response to replication fork stalling, hSSB1
S134 phosphorylation may also be required for cellular survival
following double-strand DNA-break formation. One-dimensional NMR
analysis of recombinant WT and S134A hexa-His-hSSB1 suggested that
this sensitivity was not due to misfolding of the S134A mutant and was
indeed likely due to a functional requirement of S134 phosphorylation
following DNA damage (Fig. S2A).
It is interesting to note that while S134 and T117 are highly
conserved in primates, they are less so in other animals (Fig S3A).
Indeed, serine is not present at residue 134 in either mice or rats. These
observations may be consistent with the previously reported functional
discrepancies between human and murine SSB1 orthologues [23],
which presumably undergo diﬀerential regulation. Despite the lack of
site-speciﬁc conservation of an SQ motif at S134, we did however notice
amongst the vast majority of species examined, the presence of one or
more SQ/TQ motifs within an∼ 40 amino acid region from residue 117
to 160. This observation may suggest that in those species not
phosphorylated at S134 or T117, regulation may instead be achieved
by phosphorylation of an alternative proximal residue. In addition, we
noted that unlike hSSB1, hSSB2 does not contain SQ or TQ motifs (Fig
S3B). This is consistent with suggestions that hSSB1 regulation may be
more complex than that of hSSB2, as is also evidenced by the reported
lack of detectable hSSB2 acetylation [15].
3.3. Immunodetection of S134 phosphorylation in response to replication
stress
As our data now suggest that hSSB1 is likely phosphorylated at
S134, we sought to conﬁrm this by immunodetection. A rabbit
polyclonal antibody was therefore generated using a S134 phosphory-
lated peptide representing hSSB1 residues 131–140. Using this anti-
body, phosphorylation of immunoprecipitated endogenous hSSB1 could
be detected following HU treatment, in a time-dependent manner
(Fig. 3A). Phosphorylation was however most readily detected by
immunoblotting of whole cell lysates from HeLa cells transiently
expressing WT 3x FLAG hSSB1 (Fig. 3B). An increase in S134
phosphorylation was also detected for transiently expressed hSSB1,
increasing for up to 20 h post-HU addition. Here, hSSB1 was phos-
phorylated at a similar rate to RPA32 (Fig. 3C), another ssDNA-binding
protein that is rapidly phosphorylated following replication stress [24].
Speciﬁcity of the pS134 antibody for phosphorylated hSSB1 was
conﬁrmed by expression of a S134A 3x FLAG hSSB1 mutant, as well
as by treatment of whole cell lysates with lambda phosphatase (λPPase)
and by use of a phosphorylated peptide to block antigen recognition by
the antibody (Fig. 3B). Speciﬁcity was further enhanced by inclusion of
a non-phosphorylated control peptide of otherwise identical sequence
to the blocking peptide in all phospho-antibody working solutions. An
increase in hSSB1 S134 phosphorylation was also observed following
treatment of cells with 6 μg μL−1 aphidicolin for 4, 8 and 12 h (Fig. 3D),
or with 1 μM camptothecin for 1 h (Fig. 3E).
In addition to the response to replication inhibition, hSSB1 also
functions in the repair of double-stranded
DNA breaks. We therefore reasoned that hSSB1 might also be
phosphorylated following the formation of these lesions. To assess this,
HeLa cells expressing WT 3x FLAG hSSB1 were exposed to 6 Gy of
ionising radiation and collected after 0.5, 1, 2 or 4 h. Whilst robust
phosphorylation of ATM S1981 was induced by this treatment,
indicating the induction of DNA damage [25], it failed to elicit an
hSSB1 S134 phosphorylation response which was comparable to 4 h
treatment with 3 mM hydoxyurea (Fig. 3F).
Fig. 1. Detection of phosphorylated hSSB1 by mass spectrometry (A) HEK293T cells were
transiently transfected with 3x FLAG hSSB1 or an empty plasmid 24 h prior to treatment
with 3 mM hydroxyurea (HU) for 4 h. 3x FLAG hSSB1 was immunoprecipitated from
12 mg of whole cell lysate using M2 FLAG magnetic beads and separated on a BOLT
precast gel. The gel was stained using colloidal Coomassie blue G-250 and is shown in
greyscale. * = M2 FLAG IgG proteins (B). Gel slices containing 3x FLAG hSSB1 were
excised and digested with trypsin. Peptides were detected by ESI-MS/MS and data
analysed using the Mascot algorithm against the NCBI non-redundant (nr) database.
Putative phosphorylation sites detected prior to HU treatment are indicated above the
hSSB1 schematic, while those detected after treatment is indicated below. OB fold = o-
ligonucleotide/oligosaccharide-binding fold.
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3.4. hSSB1 S134 phosphorylation is predominantly mediated by DNA-PK
To determine whether hSSB1 S134 may be a substrate of ATM, ATR
or DNA-PK, HeLa cells transiently expressing 3x FLAG hSSB1 were pre-
treated with chemical inhibitors against each of these kinases 30 min
prior to addition of 3 mM HU for 4 h. While we consistently observed a
small decrease in hSSB1 phosphorylation following addition of KU-
60019 and VE-821 (inhibitors of ATM and ATR, respectively), a∼ 90%
reduction in both basal and HU-induced hSSB1 phosphorylation was
observed following treatment of cells with the DNA-PK inhibitor
NU7441 (Fig. 4A and 4B). The eﬃcacy of KU-60019 and VE-821
treatment to suppress ATM and ATR kinase activity was here conﬁrmed
by the prevention of ATM and ATR auto-phosphorylation, as well as the
phosphorylation of Chk2 T68 (for ATMi; Fig S4A) and Chk1 S345 (for
ATRi; Fig S4B), in response to genotoxic stress. As few unique DNA-PK
substrates have been described, the eﬃcacy of NU7441 to inhibit DNA-
PK was instead conﬁrmed by the ability, when co-treated with ATMi, to
limit phosphorylation of RPA32 S4/S8 following HU exposure (Fig
Fig. 2. Cells expressing S134A hSSB1 are more sensitive to replication fork disruption. (A) HeLa cells were depleted of hSSB1 using siRNA (sihSSB1) and then transfected with WT or
S134A siRNA-resistant 3x FLAG hSSB1. After 6 h, cells were seeded into wells of a 6-well plate. Remaining cells were grown for an additional 24 h and analysed by immunoblotting. (B, C,
D and E) The cells plated in (A) were incubated for 24 h and treated with 3 mM hydroxyurea (B) or 6 μg μL−1 aphidicolin (C) for 4, 8, 12, 16 or 20 h, or with 50, 100, 150, 200 or 250 nM
camptothecin for 1 h (D), prior to exchanging with fresh media. Alternatively, cells were exposed to, 1, 2, 4, or 6 Gy ionising radiation (E), or left untreated. Cells were grown for 10 days
prior to staining of colonies with methylene blue. Colonies were manually counted and normalised to untreated cells. Data is graphed as the mean ± 1 standard deviation from four
independent experiments. t tests were used to compare the ‘sihSSB1 +WT hSSB1′ and “sihSSB1 + S134A hSSB1′ datasets at each dose. ns = p > 0.05, * = p < 0.05, ** = p < 0.01,
*** = p < 0.001.
N.W. Ashton et al. DNA Repair 54 (2017) 30–39
34
S4C). The reduction in hSSB1 S134 phosphorylation observed with
DNA-PKi was also supported by similar suppression in cells depleted of
the DNA-PK catalytic subunit (DNA-PKcs) using siRNA (Fig. 4C). These
data support that while ATM and ATR may have minor roles in the
regulation of hSSB1 S134 phosphorylation, DNA-PK is most likely the
major required kinase in cells, functioning both prior to and following
replication fork disruption.
To investigate further whether DNA-PK may directly phosphorylate
hSSB1 S134, we next performed an in vitro kinase assay using puriﬁed
DNA-PK and recombinant hexa-His-hSSB1. Here we observed robust
phosphorylation of WT hexa-His-hSSB1, although not of a S134A hexa-
His-hSSB1 mutant, which was substantially increased following stimu-
lation of DNA-PK activity by the addition of sonicated DNA (Fig. 4D).
The relevance of this assay in cells was further supported by co-
immunoprecipitation of DNA-PKcs with endogenous hSSB1, indicating
that DNA-PK may be spatially available to act on hSSB1 in cells
(Fig. 4E). In these assays, whole cell lysates were treated with the
nuclease benzonase, to exclude any associations mediated by DNA.
Here, association was observed both before and following HU treat-
ment, suggesting that hSSB1 and DNA-PK may form a complex
independently of exogenous DNA damage. Indeed, these observations
are consistent with our ﬁnding that DNA-PKcs depletion or inhibition
reduces both HU-induced and basal hSSB1 S134 phosphorylation.
These ﬁndings provide evidence that hSSB1 is regulated by direct
DNA-PK phosphorylation of S134, which is enhanced following replica-
tion fork disruption.
3.5. hSSB1 S134 phosphorylation is enzymatically suppressed
In undamaged cells, several DNA repair proteins, including Chk1
and ATM are maintained in a hypo-phosphorylated state through the
function of PPP-family serine/threonine phosphatases (protein phos-
phatases (PP) 1, 2A, 4, 5, 6) [26,27]. As our data suggest that hSSB1
S134 may be partially phosphorylated in undamaged cells and then
enhanced following replication stress, we reasoned that steady-state
hSSB1 phosphorylation might also be subject to enzymatic suppression.
To test this, HeLa cells transiently expressing 3x FLAG hSSB1 were
treated with 3 mM hydroxyurea for 3.5 h, or mock treated, and then
incubated with the PPP-family phosphatase inhibitors okadaic acid
(OA) or calyculin A (CA) for 30 min (Fig. 5A). Strikingly, the treatment
of undamaged cells with 1 μM OA, which inhibits > 95% of PP2A
activity (as well the activity of PP4 and PP6) [26], or 50 nM CA, which
additionally inhibits PP1 and PP5 (as observed by Chk1 phosphoryla-
tion) [28], lead to an increase in hSSB1 S134 phosphorylation of greater
than 5- and 9-fold, respectively (Fig. 5A and B). Similar CA-induction of
S134 phosphorylation was also detected for immunoprecipitated en-
dogenous hSSB1 (Fig. 5C). An increase in hSSB1 S134 phosphorylation
of ∼ 5 fold was further observed within 5 min of CA treatment,
Fig. 3. hSSB1 is phosphorylated at S134 following replicative stress. (A) hSSB1 was immunoprecipitated from HeLa cells that had been treated with 3 mM HU for 2, 4 or 6 h, or mock-
treated. Eluted proteins were immunoblotted for total and S134 phosphorylated hSSB1. Phosphorylation of hSSB1 S134 is expressed relative to total immunoprecipitated endogenous
hSSB1. (B) HeLa cells were transfected with WT or S134A 3x FLAG hSSB1, or a vector control, 24 h prior to treatment of cells with 3 mM HU for 4 h. Whole cell lysates were prepared
from these cells and incubated either with or without addition of lambda (λ) phosphatase at 30 °C for 45 min. Whole cell lysates were then immunoblotted and probed with a polyclonal
antibody raised against the hSSB1 peptide PSA{pS}QPTTGPKC, representing hSSB1 phosphorylated at S134. To conﬁrm speciﬁcity for S134 phosphorylated hSSB1, the antibody was pre-
incubated for 30 min either with a control non-phosphorylated peptide (+ control peptide) or with the phosphorylated immunisation peptide (+ phospho peptide). Phosphorylation of
Chk1 S345 was used as a positive control for HU treatment, as well as for lambda phosphatase activity. Actin served as a loading control. Phosphorylation of hSSB1 S134 is expressed
relative to 3x FLAG hSSB1. * = non-speciﬁc band. (C) HeLa cells transiently expressing WT or S134A 3x FLAG hSSB1, or an empty vector, for 24 h were treated with 3 mM HU for 4, 8,
12, 16 or 20 h, or left untreated and then harvested. Whole cell lysates were prepared and analysed by immunoblotting. Phosphorylation of hSSB1 S134 is expressed relative to 3x FLAG
hSSB1. Phosphorylation of RPA32 is expressed as the relative ratio of the 34 kDa to 32 kDa RPA32 bands. (D and E) HeLa cells were transfected with WT or S134A 3x FLAG hSSB1, or a
vector control, 24 h prior to treatment of cells with 6 μg μL−1 aphidicolin (Aph) for 4, 8, or 12 h (D) or with 1 μM camptothecin (CPT) for 1 h (E). Whole cell lysates prepared from these
cells were analysed by immunoblotting. Phosphorylation of hSSB1 S134 is expressed relative to 3x FLAG hSSB1. (F) HeLa cells transiently expressing WT or S134A 3x FLAG hSSB1, or an
empty vector, for 24 h were treated with 3 mM HU for 4 h, or exposed to 6 Gy of ionising radiation and harvested after 0.5, 1, 2 or 4 h. Whole cell lysates were prepared and analysed by
immunoblotting. Phosphorylation of hSSB1 S134 is expressed relative to 3x FLAG hSSB1. Phosphorylation of ATM S1981 is used as a positive control for ionising radiation exposure.
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indicating the rapidity of this reaction (Fig. 5D). These ﬁndings are
particularly notable when it is considered that even after 20 h of HU
treatment, an increase of only 3.1 fold was observed (Fig. 3C).
In addition to the clear overall increase in S134 phosphorylation
observed following PPP-family phosphatase inhibition, the increase in
S134 phosphorylation observed following HU-treatment was also found
to be signiﬁcantly greater in cells treated with 1 μM OA or 50 nM CA
(Fig. 5A and B). These data may suggest that of the hSSB1 that is
phosphorylated after HU treatment, a large amount may be subse-
quently dephosphorylated, even during conditions of fork disruption.
As these observations indicate that hSSB1 S134 is also dynamically
phosphorylated and dephosphorylated during the response to replica-
tion inhibition, we further reasoned that a similar dynamic phosphor-
ylation response might explain the lack of detectable S134 phosphor-
ylation observed in response to IR exposure (Fig. 3F), despite the
apparent involvement of S134 phosphorylation in cellular survival
following such stress (Fig. 2E). To test this, we again exposed cells
expressing WT or S134A 3x FLAG hSSB1 to ionising radiation and then
co-treated with 50 nM CA 30 min prior to harvesting (Fig. 5E and F).
Whilst we again did not observe an IR-induced increase in S134
phosphorylation in non-CA treated cells, a marked increase in S134
phosphorylation was readily detected in those cells in which phospha-
tases had been inhibited. These data thereby suggest that hSSB1 S134
may be increasingly phosphorylated in response to DNA damage,
including in response to IR treatment, although that opposing de-
phosphorylation may also concurrently occur.
3.6. S134E phosphomimetic hSSB1 binds DNA similarly to WT
In the above sections we have demonstrated that hSSB1 S134 is
dynamically phosphorylated and that this modiﬁcation promotes
cellular survival in response to replication fork disruption, as well as
double-strand DNA break formation. It was therefore interesting to
consider how S134 phosphorylation may aﬀect the molecular function
of hSSB1.
The C-terminal tail of hSSB1 was recently described as important for
eﬃcient DNA-binding [29]. The position of S134 at the start of this
region therefore raised the possibility that phosphorylation of this
residue may alter the interaction of hSSB1 with DNA. To assess this,
recombinant WT and S134E hexa-His-hSSB1 was puriﬁed from E. coli
and the ssDNA-binding capacity of each protein measured using
BioLayer interferometry (BLI). Although hSSB1 has previously being
described as an ssDNA-binding protein with negligible aﬃnity for
dsDNA [14,30], we also assessed the binding of WT and S134E hSSB1
to a fork junction substrate lacking exposed ssDNA [20], representing a
structure likely to form in the processing of disrupted replication forks.
Whilst hSSB1 was indeed able to bind a fork junction substrate, albeit
with lower aﬃnity than ssDNA, we however did not detect any
statistically signiﬁcant diﬀerence in binding between WT and S134E
hSSB1 for either substrate (Fig. 6). These data thereby suggest an
alteration of DNA-binding activity is an unlikely function of hSSB1
S134 phosphorylation.
4. Discussion
Enzymatically active DNA-PK is a central component of the cellular
response to replication fork inhibition [6]. For instance, cells depleted
of endogenous DNA-PKcs or expressing an enzymatically deﬁcient
kinase mutant are unable to eﬃciently restart stalled replication forks
and show reduced clonogenic survival when treated with hydroxyurea
[7]. With the notable exception of RPA32 [8], as well as of auto-
phosphorylation [7], few relevant DNA-PK substrates have however
been identiﬁed in response to replication stress. In this article we
demonstrate that hSSB1 S134 phosphorylation is required for clono-
genic survival of cells treated with the replication stress compounds
hydroxyurea, aphidicolin and camptothecin, as well as establish that
phosphorylation is primarily a result of DNA-PK activity. As a small
decrease in hSSB1 S134 phosphorylation was also observed following
the inhibition of ATM and ATR, we cannot however exclude that these
kinases may also contribute a small amount to the phosphorylation of
Fig. 4. hSSB1 S134 is phosphorylated by DNA-PK. (A) HeLa cells transiently expressing WT or S134A 3x FLAG hSSB1, or an empty vector, for 24 h were pre-treated with 5 μM KU-60019
(ATMi), 10 μM VE-821 (ATRi), 5 μM NU7441 (DNA-PKi), or DMSO (control) for 30 min, prior to treatment with 3 mM HU for 4 h. Whole cell lysates were then prepared and analysed by
immunoblotting. Phosphorylation of hSSB1 S134 is expressed relative to 3x FLAG hSSB1. (B) Bar graph illustrating relative hSSB1 S134 phosphorylation from 3 independent repeats of
(A). Data is graphed as the mean ± 1 standard deviation. t tests were used to compare phosphorylation of hSSB1 S134 for each inhibitor data set relative to DMSO lanes for each dose.
* = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001. (C) DNA-PKcs was depleted from HeLa cells by transfection with 10 nM Silencer Select siRNA twice, separated
by 24 h incubation, followed by transient expression of WT or S134A 3x FLAG hSSB1, or an empty control, after an additional 24 h. Cells were then treated with 3 mM HU for 4 h and
whole cell lysates analysed by immunoblotting. Phosphorylation of hSSB1 S134 is expressed relative to 3x FLAG hSSB1. (D) 500 ng of recombinant WT or S134A hexa-His-hSSB1 was
incubated with 10 U of DNA-PKcs/Ku for 30 min at 30 °C ± 100 μM ATP and 10 μg mL−1 sonicated salmon sperm DNA. Reactions were separated by PAGE and either immunoblotted
for hSSB1 S134 phosphorylation or stained with colloidal Coomassie blue (shown in greyscale). (E) hSSB1 was immunoprecipitated from whole cell lysates of HeLa cells treated ± 3 mM
HU for 4 h. Eluent nd whole cell lysate (2% input) was immoblotted as indicated.
N.W. Ashton et al. DNA Repair 54 (2017) 30–39
36
hSSB1 S134. Such overlap is consistent with previous studies on other
known PI3K-like kinase substrates and is exempliﬁed by the over-
lapping ATM and DNA-PK phosphorylation of RPA32 residues S4/8 and
S12 [8], as well as the ATM and DNA-PK phosphorylation of Chk1 S317
in cells where ATR (the predominant kinase of Chk1 S317) function is
suppressed (25). Alternatively, the reduction in hSSB1 S134 phosphor-
ylation observed following ATM and ATR inhibition might result from
indirect de-regulation of DNA-PK function. Indeed, the phosphorylation
and thereby activation of DNA-PK by ATM [31] and ATR [32] has
previously been demonstrated, the disruption of which might also
explain the small reduction in hSSB1 S134 phosphorylation observed
following inhibition of these enzymes.
While hSSB1 S134 is also phosphorylated by DNA-PK in undamaged
cells, this may be maintained at steady-state levels by the opposing
activities of PPP-family protein phosphatases. This family includes
numerous members that are inhibited by okadaic acid in cells, includ-
ing PP2A, PP4, PP5, and PP6 (23). The increase in hSSB1 phosphoryla-
tion observed following treatment with okadaic acid therefore suggests
the involvement of one of these enzymes in the de-phosphorylation of
hSSB1. Indeed, each of these enzymes has previously been implicated in
the regulation of DNA repair pathways [33] and may represent
plausible regulators of hSSB1. Although we did observe an additional
Fig. 5. hSSB1 S134 phosphorylation is regulated by PPP-family protein phosphatases. (A) HeLa cells transiently expressing WT or S134A 3x FLAG hSSB1, or an empty vector, for 24 h
were treated with 3 mM HU for 3.5 h prior to addition of 25 nM okadaic acid (OA), 1 μM OA, or 50 nM calyculin A (CA) for 30 min. Whole cell lysates were prepared and immunoblotted
for phosphorylation of hSSB1 S134. Phosphorylation of hSSB1 S134 is expressed relative to 3x FLAG hSSB1. (B) Bar graph illustrating the relative levels of hSSB1 S134 phosphorylation
from three independent repeats of (A). Data is graphed as the mean ± 1 standard deviation. t tests were used to compare phosphorylation of hSSB1 S134 for each inhibitor data set
relative to DMSO lanes for untreated and 3 mM HU treated samples (above the bars). t tests were also used to compare the HU-induced increase in S134 phosphorylation following
phosphatase treatment (above the lines) * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001. (C) hSSB1 was immunoprecipitated from HeLa cells that had been
treated with 50 nM CA for 30 min, or mock-treated. Eluted proteins were immunoblotted for total and S134 phosphorylated hSSB1. Phosphorylation of hSSB1 S134 is expressed relative
to total immunoprecipitated endogenous hSSB1. (D) HeLa cells expressing WT or S134A 3x FLAG hSSB1 were treated with 50 nM CA for 5, 10, 20 or 30 min. Whole cell lysates were
prepared and analysed by immunoblotting. Phosphorylation of hSSB1 S134 is expressed relative to 3x FLAG hSSB1. (E) HeLa cells transiently expressing WT or S134A 3x FLAG hSSB1, or
an empty vector, for 24 h were either left untreated or exposed to 6 Gy of ionising radiation and harvested after 1, 2 or 4 h. Thirty minutes prior to harvesting, cells were also
treated ± 50 nM CA. Whole cell lysates were prepared and immunoblotted for phosphorylation of hSSB1 S134, which is expressed relative to 3x FLAG hSSB1. (F) Bar graph illustrating
the relative levels of hSSB1 S134 phosphorylation from three independent repeats of (G). Data is graphed as the mean ± 1 standard deviation. t tests were used to compare
phosphorylation of hSSB1 S134 from those cells exposed to ionising radiation with the unexposed lanes within each data set (±CA) A t test was also used to compare phosphorylation of
hSSB1 S134 from CA treated and untreated non-irradiated cells. ns = non signiﬁcant, * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.
Fig. 6. S134E phosphomimetic hSSB1 binds DNA similarly to WT DNA binding of WT and
S134E recombinant hexa-His-hSSB1 was assessed by BioLayer interferometry and the
dissociation constants of each protein for single-stranded and fork DNA substrates
determined. Data is graphed as the mean ± 1 standard deviation. t tests were used to
compare the dissociation constants for each substrate. ns = non signiﬁcant (p > 0.05).
The schematics below each pair of columns represent the tested DNA substrates where
* = biotin.
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increase in hSSB1 phosphorylation when calcyculin A was added to
cells, a compound that also inhibits PP1, it is unclear whether the
greater aﬀect observed here with comparison to okadaic acid treatment
is due to PP1 involvement. Indeed, calyculin A also shows increased
potency towards PP5, the involvement of which also represents a
plausible explanation. Further studies will therefore be required to
establish which PPP-family members are involved in dephosphorylating
hSSB1 S134. Such experiments, which would likely require the speciﬁc
depletion of individual PPP-family member subunits, may however be
hampered by potential indirect aﬀects which may arise due to disrup-
tion of dephosphorylation events required for proper regulation of
DNA-PK or of DNA-PK regulatory proteins. Indeed, we cannot exclude
the possibility that such indirect aﬀects may account for some of the
increased hSSB1 S134 phosphorylation observed here following caly-
culin A and okadaic acid treatment. In addition, as both of these
compounds are know to have cytotoxic aﬀects on cells [34], we cannot
exclude, based on our data, that hSSB1 S134 may be phosphorylated as
a result of these cellular changes, independently of direct disruption of
dynamic phosphorylation.
It is of interest to consider an explanation for the apparent
phosphorylation of hSSB1 in undamaged cells. One such may be that
in order to execute a rapid response to replication inhibition, basal S134
phosphorylation could function to keep hSSB1 in a ‘primed’ state prior
to stress. Such an arrangement may be consistent with our previous
description of hSSB1 as an early responder to DNA damage. This is
demonstrated by the rapid co-localisation of hSSB1 with sites of stalled
replication in response to hydroxyurea treatment and its subsequent
roles in ATR recruitment [11]. A similar ‘priming’ approach has also
been suggested for Chk1, where phosphorylation of S317 and S345 is
maintained under a suppressive state by PP1 during un-perturbed cell
cycles to allow for rapid checkpoint activation in response to replication
fork stalling [27]. As basal hSSB1 phosphorylation may involve DNA-
PK function, this scenario suggests that a pool of activated DNA-PK
must also exist in un-exogenously damaged cells. This is supported by
the similar increase in DNA-PK auto-phosphorylation that has been
observed following okadaic acid treatment of cells [35], or depletion of
PP5 [33]. It is worth noting, however, that basal phosphorylation of
RPA32 S33 was also observed in cells, which increased at a similar rate
to hSSB1 S134 phosphorylation following hydroxyurea treatment.
RPA32 S33 phosphorylation in undamaged cells has previously been
found to occur in the late S- and G2 phases of the cell cycle and has been
attributed to the persistence of endogenously stalled replication forks
[24]. A similar regulatory mechanism may thereby also explain the
detection of S134 phosphorylated hSSB1 in undamaged cells. As
detection of S134 phosphorylation predominantly required transient
overexpression of hSSB1, we cannot however rule out that the high
degree of basal hSSB1 phosphorylation observed was due the equili-
brium between S134 phosphorylation and de-phosphorylation being
somewhat altered from endogenous ratios.
Whilst our studies of WT and S134E hSSB1 DNA-binding did not
yield any additional insight into the molecular function of S134
phosphorylation, we were surprised to ﬁnd that hSSB1 can bind fork
substrates, especially given the negligible interaction of hSSB1 with
dsDNA duplexes reported previously [14]. Interestingly, a similar
observation was recently reported for the annealing helicase SMARC-
AL1, a protein that also has minimal aﬃnity for dsDNA, although which
readily binds model replication forks lacking exposed ssDNA [36]. In
this work, the authors suggested SMARCAL1 might capture small
amounts of ssDNA that are exposed due to ‘breathing’ of the dsDNA
regions adjacent to the fork junction. It is tempting to consider that
hSSB1 may bind this structure through a similar means. Indeed, these
results are somewhat reminiscent of our ﬁnding that hSSB1 is able to
bind a dsDNA substrate containing a single 8-oxoguanine modiﬁcation,
potentially due to a similar localised de-stabilisation of the DNA duplex
[14]. Although we have previously demonstrated that hSSB1 localises
to replication forks following their disruption [11], the mechanistic
consequence of fork-junction binding however remains unclear. These
data nevertheless suggest that S134 phosphorylation is unlikely to alter
hSSB1 DNA-binding and may instead alter hSSB1 via an alternative
means, such as by modulating the interaction with an as yet unidenti-
ﬁed protein-binding partner.
We were also interested to note that despite the lack of site-speciﬁc
conservation of an SQ motif at S134 outside of primates, numerous
other animal species also contain SQ/TQ motifs within an∼ 40 amino
acid region homologous to hSSB1 residues 117–160. This includes in
distantly related animals, such as in reptiles, amphibians and ﬁsh.
Although the modiﬁcation of these putative PI3K-like kinase phosphor-
ylation motifs remains unexplored, the presence of these motifs in the
vast majority of species examined may suggest that despite low speciﬁc
conservation of hSSB1 S134 (or T117), selective pressure may exist for
the occurrence of phosphorylation sites within this region of SSB1
homologues. Whether these additional SQ/TQ motifs are indeed
phosphorylated and alter SSB1 function by a means similar to S134
phosphorylation, will however require additional experimentation.
In summary, the data presented here indicate that hSSB1 phosphor-
ylation at S134 is dynamically regulated by DNA-PK and PPP-family
protein phosphatases. Furthermore, this modiﬁcation is enhanced
following replication inhibition and promotes hSSB1-mediated cell
survival. These data thereby suggest a novel mechanism utilised by
cells in the response to DNA damage. As such stress is induced by
numerous chemotherapeutics, the disruption of hSSB1 S134 phosphor-
ylation may therefore represent an eﬀective target for the sensitisation
of cancer cells.
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